AppealFlow
100% FreePharmacyNo login requiredAbout 3 minutes

Step therapy exception appeal generator

Request a step-therapy exception when required drugs failed or are contraindicated.

Step therapy (“fail first”) requires trying a plan-preferred drug before the one prescribed. An exception is appropriate when the preferred drug was already tried, caused harm, is expected to be ineffective, or is contraindicated. Many states regulate step-therapy exceptions for fully insured plans; self-funded ERISA plans follow federal claims procedure and the plan document. Medicare Part D has its own exception process.

  • 100% free
  • No login required
  • Export & print

Loading generator…

Complete guide

How to request a step-therapy exception

Generate a step-therapy exception letter that names each required drug and why it fails.

How this tool works

  1. You enter denial facts from your EOB or denial letter — member ID, claim number, service, and the reason the payer gave.
  2. AppealFlow drafts structured appeal language you can edit in the browser. Optional checkboxes add ERISA full-and-fair-review language, No Surprises Act references, or expedited-review requests when they fit your facts.
  3. Export PDF or Word, keep a copy for your records, and file through the portal, fax, or mailing address on your notice before the deadline printed there.

Internal appeals ask the plan to reconsider its own adverse benefit determination. You are not debating fairness in general — you are showing why the decision failed the plan's medical policy, authorization rules, or billing edits.

Keep a single timeline document with denial date, appeal submission date, follow-up calls, and any additional information requests. This record supports state department complaints if the carrier misses required response times under 29 CFR 2560.503-1 or state analogs.

When clinical criteria are cited, request the plan medical policy the reviewer used. You may obtain it through member services or a written request. Compare each criterion to your chart note rather than quoting internet summaries.

Who this is for

  • Patients told to try Drug A before Drug B
  • Prescribers documenting contraindications to the preferred agent
  • Members with a pharmacy reject for step therapy on GLP-1, biologic, or specialty drugs
  • Convenience or brand preference without clinical reasons is a weak exception
  • Imaging “fail first” (PT before MRI) uses imaging policies, not this pharmacy template

Step-by-step workflow

  1. Step 1: Name the required step drugs

    Copy them from the PA denial. Your letter should address each required step, not a generic “I don’t want cheaper drugs.”

  2. Step 2: Document trials, duration, and outcome

    Dates, dose, and why it failed or stopped (allergy, adverse effect, no response). Chart notes beat memory.

  3. Step 3: State contraindications clearly

    If the step drug is unsafe (for example NSAID step in someone with GI bleed history), say so with the diagnosis.

  4. Step 4: Check state step-therapy laws if fully insured

    Some states set exception timeframes or require granting exceptions in defined clinical situations. Self-funded employer plans may not be covered by those state laws.

  5. Step 5: Complete the PBM exception form

    Use CoverMyMeds or the portal on your Rx card. The prescriber attestation must name each preferred alternative and why it is not appropriate.

  6. Step 6: File exception and plan appeal in parallel

    Complete the PBM exception and keep the health-plan appeal deadline on the EOB. Save confirmation numbers for both channels.

Worked example: estimating a 180-day internal window

Your commercial plan sends an adverse benefit determination dated March 15, 2026 denying physical therapy as not medically necessary. The notice says you may request an internal appeal within 180 days.

Adding 180 calendar days to March 15 lands on September 11, 2026 (verify with your plan — some policies use business days or a fixed date on the form). If you need continued care while waiting, ask whether the plan offers an expedited review and document any worsening symptoms.

If the internal appeal is upheld, the same notice often explains whether you may request external review and which state or federal program applies. Save portal uploads, fax confirmations, and certified mail receipts.

Appeal deadlines by plan type (reference)

Deadlines are plan-specific. The table summarizes common federal frameworks cited on many notices. Your adverse benefit determination letter controls filing dates and channels.

Plan typeInternal appealExternal reviewUrgent / expedited
ACA marketplace / fully insured individual & small groupOften 60–180 days from the adverse determination (check notice). ACA internal claims and appeals rules require written notice of rights.After exhausting internal appeals, many enrollees may request external review; federal rules set minimum external review rights for qualifying plans (see 45 CFR 147.136).Urgent medical situations may qualify for expedited review; many plans must respond within 72 hours when delay could seriously jeopardize health (45 CFR 147.136(b)(3) framework).
Self-funded employer plan (ERISA)29 CFR 2560.503-1 requires a reasonable opportunity for a full and fair review; many plans allow about 180 days to request review of an adverse benefit determination unless the plan document grants longer.External review rights depend on plan design and state law for insured portions; many ERISA plans use independent review vendors after internal exhaustion.Expedited review must be available when the timeframe for a standard review could seriously jeopardize life or health (29 CFR 2560.503-1(h)(3)(i)).
Original Medicare (Part A & B)Medicare uses redetermination (Level 1) by the Medicare Administrative Contractor — typically 120 days from the date of the initial determination on the MSN.Reconsideration (Level 2), ALJ hearing, and further levels follow CMS Medicare appeals guidance — not the same clocks as commercial insurance.Expedited Medicare determinations exist for certain hospital and SNF situations; follow instructions on the MSN.
Medicare Advantage (Part C)Organization determination and plan-level appeals follow CMS Medicare Advantage rules; use the plan's forms and clocks on the denial.After plan-level appeals, enrollees may request CMS review or, for some issues, state external review when applicable.Part C plans must offer expedited reviews for urgent requests per CMS marketing/appeals requirements.
Medicare Part D (prescription drugs)Coverage determinations and exceptions use PBM/plan Part D forms; standard determination timeframes are set in CMS Part D regulations.Appeal to the Independent Review Entity (IRE) after plan-level denial of a standard or expedited determination.Expedited exceptions and appeals exist when waiting could seriously harm health; request expedited processing in writing.
Medicaid / CHIP (state)Each state Medicaid agency sets fair hearing and appeal timelines; use the notice from your managed care plan or state agency.State fair hearing after managed care appeal exhaustion; timelines vary by state and benefit type.Many states allow expedited hearings when delay would jeopardize health; cite urgency on the request form.

Cite 29 CFR 2560.503-1 for many ERISA group health plans and 45 CFR 147.136 for many non-grandfathered individual/small group plans. Medicare and Medicaid use separate statutes and forms.

Documents to gather

  • PA denial listing required steps
  • Medication history / pharmacy fill records
  • Allergy and adverse-effect notes
  • Prescriber attestation
  • PBM exception form or CoverMyMeds submission

Exception decision times can be days, not months, especially for Part D. Start when the pharmacy rejects the claim.

Weak vs strong wording

Weak

Step therapy is unfair and delays care.

Stronger

Plan requires metformin then GLP-1. Metformin 2000 mg daily 2023–2024 stopped for eGFR decline (labs attached). Request exception to start [drug] now; repeating metformin is contraindicated.

You must retire the specific required step with evidence.

Weak

I already tried the generic and it did not work.

Stronger

Required step drug [name] 40 mg daily 1/2025–4/2025 with no A1C improvement (labs attached). Preferred alternative [name] is contraindicated due to [diagnosis]. Request step-therapy exception for [prescribed drug].

Reviewers need dates, dose, outcome, and why each listed step drug fails.

Weak

My doctor says I need the brand drug now.

Stronger

PA denial lists step 1 [drug A] and step 2 [drug B]. Drug A caused [adverse effect] on [date] (clinic note attached). Drug B is contraindicated with [condition]. Request exception to start [prescribed drug] without repeating unsafe steps.

The prescriber’s opinion helps only when tied to documented trials or contraindications.

Common mistakes

  • Saying you “tried diet and exercise” when the required step is a listed drug
  • Applying a state step-therapy statute to a self-funded ERISA plan without checking
  • Filing only with medical claims when the reject is a PBM formulary or step-therapy code
  • Restarting a drug that caused a documented adverse reaction without explaining why retrial is unsafe

What to do next

  • Save proof of filing (portal screenshot, fax confirmation, or certified mail receipt).
  • If the plan requests more records, respond within the timeframe on the follow-up letter.
  • When internal appeals are exhausted, read your notice for external review or state complaint rights.
  • Need deadlines, evidence lists, and filing checklists in one download? Consider the matching AppealFlow pack on the pricing page (document prep only).
  • Optional paid pack: Appeal Pack (document preparation only).

Authoritative sources

Related tools and guides

FAQs

Have the prescriber sign, then file with the PBM before you miss the determination clock.

Free draft tool · Review with your clinician · Not legal or medical advice · Disclaimer